153 related articles for article (PubMed ID: 37337223)
1. PSMD3-ILF3 signaling cascade drives lung cancer cell proliferation and migration.
Zhang J; Ma Q; Yu Q; Xiao F; Zhang Z; Feng H; Liang C
Biol Direct; 2023 Jun; 18(1):33. PubMed ID: 37337223
[TBL] [Abstract][Full Text] [Related]
2. Ox-LDL-mediated ILF3 overexpression in gastric cancer progression by activating the PI3K/AKT/mTOR signaling pathway.
Sun D; Zhang M; Wei M; Wang Z; Qiao W; Liu P; Zhong X; Liang Y; Chen Y; Huang Y; Yu W
Aging (Albany NY); 2022 May; 14(9):3887-3909. PubMed ID: 35507914
[TBL] [Abstract][Full Text] [Related]
3. EGFR-mediated interleukin enhancer-binding factor 3 contributes to formation and survival of cancer stem-like tumorspheres as a therapeutic target against EGFR-positive non-small cell lung cancer.
Cheng CC; Chou KF; Wu CW; Su NW; Peng CL; Su YW; Chang J; Ho AS; Lin HC; Chen CG; Yang BL; Chang YC; Chiang YW; Lim KH; Chang YF
Lung Cancer; 2018 Feb; 116():80-89. PubMed ID: 29413056
[TBL] [Abstract][Full Text] [Related]
4. Proteasome 26S Subunit, non-ATPase 3 (PSMD3) Regulates Breast Cancer by Stabilizing HER2 from Degradation.
Fararjeh AS; Chen LC; Ho YS; Cheng TC; Liu YR; Chang HL; Chang HW; Wu CH; Tu SH
Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 31013812
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of ERp57 promotes clear cell renal cell carcinoma progression by initiating a STAT3/ILF3 feedback loop.
Liu Y; Wang JX; Nie ZY; Wen Y; Jia XJ; Zhang LN; Duan HJ; Shi YH
J Exp Clin Cancer Res; 2019 Oct; 38(1):439. PubMed ID: 31747963
[TBL] [Abstract][Full Text] [Related]
6. Up-regulated long non-coding RNA ILF3-AS1 indicates poor prognosis of nasopharyngeal carcinoma and promoted cell metastasis.
Yang X; Lin F; Gao F
Int J Biol Markers; 2020 Dec; 35(4):61-70. PubMed ID: 32962500
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA ILF3-AS1 facilitates hepatocellular carcinoma progression by stabilizing ILF3 mRNA in an m
Bo C; Li N; He L; Zhang S; An Y
Hum Cell; 2021 Nov; 34(6):1843-1854. PubMed ID: 34491544
[TBL] [Abstract][Full Text] [Related]
8. Interleukin enhancer-binding factor 3 promotes breast tumor progression by regulating sustained urokinase-type plasminogen activator expression.
Hu Q; Lu YY; Noh H; Hong S; Dong Z; Ding HF; Su SB; Huang S
Oncogene; 2013 Aug; 32(34):3933-43. PubMed ID: 22986534
[TBL] [Abstract][Full Text] [Related]
9. RNA binding protein POP7 regulates ILF3 mRNA stability and expression to promote breast cancer progression.
Huang Y; Zheng Y; Yao L; Qiao F; Hou Y; Hu X; Li D; Shao Z
Cancer Sci; 2022 Nov; 113(11):3801-3813. PubMed ID: 35579257
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA ILF3-AS1 regulates myocardial infarction via the miR-212-3p/SIRT1 axis and PI3K/Akt signaling pathway.
Zhang JY; Yang Z; Fang K; Shi ZL; Ren DH; Sun J
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2647-2658. PubMed ID: 32196615
[TBL] [Abstract][Full Text] [Related]
11. LncRNA ILF3-AS1 promotes cell migration, invasion and EMT process in hepatocellular carcinoma via the miR-628-5p/MEIS2 axis to activate the Notch pathway.
Yan G; Chang Z; Wang C; Gong Z; Xin H; Liu Z
Dig Liver Dis; 2022 Jan; 54(1):125-135. PubMed ID: 34053876
[TBL] [Abstract][Full Text] [Related]
12. 26S Proteasome Non-ATPase Regulatory Subunits 1 (PSMD1) and 3 (PSMD3) as Putative Targets for Cancer Prognosis and Therapy.
Rubio AJ; Bencomo-Alvarez AE; Young JE; Velazquez VV; Lara JJ; Gonzalez MA; Eiring AM
Cells; 2021 Sep; 10(9):. PubMed ID: 34572038
[TBL] [Abstract][Full Text] [Related]
13. ILF3 promotes gastric cancer proliferation and may be used as a prognostic marker.
Liu Y; Li Y; Zhao Y; Liu Y; Fan L; Jia N; Zhao Q
Mol Med Rep; 2019 Jul; 20(1):125-134. PubMed ID: 31115508
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA ILF3-AS1 promotes cell proliferation, migration, and invasion via negatively regulating miR-200b/a/429 in melanoma.
Chen X; Liu S; Zhao X; Ma X; Gao G; Yu L; Yan D; Dong H; Sun W
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28935763
[TBL] [Abstract][Full Text] [Related]
15. LncRNA ILF3-AS1 Promotes the Progression of Colon Adenocarcinoma Cells Through the miR-619-5p/CAMK1D Axis.
Liu W; Li S
Onco Targets Ther; 2021; 14():1861-1872. PubMed ID: 33737811
[TBL] [Abstract][Full Text] [Related]
16. Astragaloside IV promotes keratinocyte proliferation and migration through upregulating lncRNA H19 recruited ILF3 to enhance the stability of CDK4 mRNA.
Wang DD; Zhang LZ; Pang CJ; Ye JZ
Kaohsiung J Med Sci; 2023 Aug; 39(8):811-823. PubMed ID: 37132584
[TBL] [Abstract][Full Text] [Related]
17. The long non-coding RNA ILF3-AS1 increases the proliferation and invasion of retinoblastoma through the miR-132-3p/SMAD2 axis.
Han S; Song L; Chen Y; Hou M; Wei X; Fan D
Exp Cell Res; 2020 Aug; 393(2):112087. PubMed ID: 32407730
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic splicing factor SRSF3 regulates ILF3 alternative splicing to promote cancer cell proliferation and transformation.
Jia R; Ajiro M; Yu L; McCoy P; Zheng ZM
RNA; 2019 May; 25(5):630-644. PubMed ID: 30796096
[TBL] [Abstract][Full Text] [Related]
19. ILF3 is a substrate of SPOP for regulating serine biosynthesis in colorectal cancer.
Li K; Wu JL; Qin B; Fan Z; Tang Q; Lu W; Zhang H; Xing F; Meng M; Zou S; Wei W; Chen H; Cai J; Wang H; Zhang H; Cai J; Fang L; Bian X; Chen C; Lan P; Ghesquière B; Fang L; Lee MH
Cell Res; 2020 Feb; 30(2):163-178. PubMed ID: 31772275
[TBL] [Abstract][Full Text] [Related]
20. Characterization of circSCL38A1 as a novel oncogene in bladder cancer via targeting ILF3/TGF-β2 signaling axis.
Li P; Mi Q; Yan S; Xie Y; Cui Z; Zhang S; Wang Y; Gao H; Wang Y; Li J; Du L; Wang C
Cell Death Dis; 2023 Jan; 14(1):59. PubMed ID: 36697384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
